Idioma:

Osteonecrosis of the jaw induced by orally administered bisphosphonates : incidence, clinical features, predisposing factors and treatment outcome

YAROM, N ; YAHALOM, R ; SHOSHANI, Y ; HAMED, W ; REGEV, E ; ELAD, S

Osteoporosis international, 2007-10, Vol.18 (10), p.1363-1370 [Periódico revisado por pares]

London: Springer

Texto completo disponível

Citações Citado por

Enviar para

Título:
Osteonecrosis of the jaw induced by orally administered bisphosphonates : incidence, clinical features, predisposing factors and treatment outcome
Autor: YAROM, N ; YAHALOM, R ; SHOSHANI, Y ; HAMED, W ; REGEV, E ; ELAD, S
Assuntos: Aged ; Bacterial arthritis and osteitis ; Bacterial diseases ; Biological and medical sciences ; Bone Density Conservation Agents - adverse effects ; Bone Density Conservation Agents - metabolism ; Bones, joints and connective tissue. Antiinflammatory agents ; Clinical outcomes ; Dental Care - adverse effects ; Diphosphonates - adverse effects ; Diphosphonates - metabolism ; Diseases of the osteoarticular system ; Drug therapy ; Female ; Head ; Human bacterial diseases ; Humans ; Infectious diseases ; Jaw Diseases - chemically induced ; Jaw Diseases - diagnosis ; Jaw Diseases - drug therapy ; Medical sciences ; Middle Aged ; Mouth ; Osteonecrosis - chemically induced ; Osteonecrosis - diagnosis ; Osteonecrosis - drug therapy ; Osteoporosis ; Osteoporosis - drug therapy ; Pharmacology. Drug treatments ; Quality of Life - psychology ; Retrospective Studies ; Side effects ; Smoking - adverse effects ; Treatment Outcome ; Vascular bone diseases
É parte de: Osteoporosis international, 2007-10, Vol.18 (10), p.1363-1370
Descrição: Osteonecrosis of the jaw (ONJ) is a well-known devastating side effect of bisphosphonate therapy for cancer. Several ONJ cases of patients using oral bisphosphonates have been reported in the literature. The present study analyzed the clinical features, predisposing factors, and treatment outcome of 11 patients with oral bisphosphonates-related ONJ. Osteonecrosis of the jaw (ONJ) is a well-known side effect of parenteral bisphosphonates therapy. Although ONJ has been reported in patients using oral bisphosphonates, documentation of this entity is sparse. It was hypothesized that the clinical features, predisposing factors, and treatment outcome of this population are different from those of oncologic patients. This retrospective bi-central study involved 98 ONJ patients, 13 of whom were treated with oral bisphosphonates. Two patients were excluded because of previous use of intravenous bisphosphonates. The profiles of 11 patients were analyzed. The mean duration of alendronate use before developing ONJ was 4.1 years. ONJ was triggered by dental surgery in 9 patients and by ill-fitted dentures in 2. Heavy smokers were the most recalcitrant subjects. Among the nine patients with at least 6 months of follow-up, ONJ healed completely in three, partially in four, and not at all in two. ONJ is a rare devastating side effect of oral bisphosphonates associated with patient morbidity and high financial burden. Clinicians must be aware of this entity and inform patients of the risks of dental surgery. The synergistic effect of smoking in the pathogenesis of ONJ should be further investigated.
Editor: London: Springer
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Osteonecrosis of the jaw induced by orally administered bisphosphonates : incidence, clinical features, predisposing factors and treatment outcome

YAROM, N ; YAHALOM, R ; SHOSHANI, Y ; HAMED, W ; REGEV, E ; ELAD, S

London: Springer

Buscando em bases de dados remotas. Favor aguardar.